Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
ACS Chemical Biology|September 7, 2011
Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogueAnat Frydman-Marom, Marino Convertino, Riccardo Pellarin, et al.
Angewandte Chemie (International Ed. in English)|November 18, 2021
Inhibitor-Mediated Structural Transition in a Minimal Amyloid ModelPriyadarshi Chakraborty, Santu Bera, Phil Mickel, et al.
Urology|January 9, 2021
Urology Residency Training in Medically Underserved Areas Through the Integration of a Federally Qualified Health Center RotationJuan F Javier-DesLoges, Daniel Segal, Amir Khan, et al.
Cellular and Molecular Life Sciences : CMLS|September 14, 2020
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegenerationYelena Losev, Moran Frenkel-Pinter, Malak Abu-Hussien, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2002
Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate developmentLan Chen, Daniel Segal, Neil A Hukriede, et al.
Molecular Systems Biology|May 9, 2007
Genomic analysis of COP9 signalosome function in Drosophila melanogaster reveals a role in temporal regulation of gene expressionEfrat Oron, Tamir Tuller, Ling Li, et al.
Chemical Communications (Cambridge, England)|November 21, 2019
Tryptophan-glucosamine conjugates modulate tau-derived PHF6 aggregation at low concentrationsAshim Paul, Wen-Hao Li, Guru KrishnaKumar Viswanathan, et al.
Neurobiology of Aging|May 30, 2017
Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model DrosophilaMoran Frenkel-Pinter, Shiri Stempler, Sharon Tal-Mazaki, et al.
The Journal of Biological Chemistry|May 3, 2013
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein, et al.
Plos One|February 10, 2011
Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal modelsAnat Frydman-Marom, Aviad Levin, Dorit Farfara, et al.
Pageof 10